1,257
Views
12
CrossRef citations to date
0
Altmetric
Commentary

How to determine protective immunity in the post-vaccine era

, &
Pages 903-906 | Received 18 Nov 2015, Accepted 02 Dec 2015, Published online: 13 May 2016

References

  • O'Shea S, Best JM, Banatvala JE. Viremia, virus excretion, and antibody responses after challenge in volunteers with low levels of antibody to rubella virus. J Infect Dis 1983; 148:639-47; PMID:6355309; http://dx.doi.org/10.1093/infdis/148.4.639
  • Tingle AJ, Mitchell LA, Grace M, Middleton P, Mathias R, MacWilliam L, Chalmers A. Randomised double-blind placebo-controlled study on adverse effects of rubella immunisation in seronegative women. Lancet 1997; 349:1277-81; PMID:9142061; http://dx.doi.org/10.1016/S0140-6736(96)12031-6
  • Lai FY, Dover DC, Lee B, Fonseca K, Solomon N, Plitt SS, Jaipaul J, Tipples GA, Charlton C. Determining rubella immunity in pregnant Alberta women 2009–2012. Vaccine 2015; 33:635-41; PMID:25533327; http://dx.doi.org/10.1016/j.vaccine.2014.12.022
  • Davidkin I, Jokinen S, Broman M, Leinikki P, Peltola H. Persistence of measles, mumps, and rubella antibodies in an MMR-vaccinated cohort: a 20-year follow-up. J Infect Dis 2008; 197:950-6; PMID:18419470; http://dx.doi.org/10.1086/528993
  • Mitchell LA, Décarie D, Tingle AJ, Lacroix M, Zrein M. Use of synthetic peptides to map regions of rubella virus capsid protein recognized by human T lymphocytes. Vaccine 1994; 12:639-45; PMID:8085383; http://dx.doi.org/10.1016/0264-410X(94)90270-4
  • Mitchell LA, Tingle AJ, Décarie D, Shukin R. Identification of rubella virus T-cell epitopes recognized in anamnestic response to RA27/3 vaccine: associations with boost in neutralizing antibody titer. Vaccine 1999; 17:2356-65; PMID:10392617; http://dx.doi.org/10.1016/S0264-410X(99)00040-7
  • Hahné S, Macey J, van Binnendijk R, Kohl R, Dolman S, van der Veen Y, Tipples G, Ruijs H, Mazzulli T, Timen A, et al. Rubella outbreak in the Netherlands, 2004-2005: high burden of congenital infection and spread to Canada. Pediatr Infect Dis J 2009; 28:795-800; http://dx.doi.org/10.1097/INF.0b013e3181a3e2d5
  • National Committee of Clinical Laboratory Scientists (NCCLS). Evaluation and Performance Criteria for Multiple Component Test Products Intended for the Detection and Quantification of Rubella IgG Antibody, I/LA6-T, Tentative Guidline. 1985 Wayne, PA
  • Robinson RG, Dudenhoeffer FE, Holroyd HJ, Baker LR, Bernstein DI, Cherry JD. Rubella immunity in older children, teenagers, and young adults: a comparison of immunity in those previously immunized with those unimmunized. J Pediatr 1982; 101:188-91; PMID:7097409; http://dx.doi.org/10.1016/S0022-3476(82)80114-5
  • Storch GA, Myers N. Latex-agglutination test for rubella antibody: validity of positive results assessed by response to immunization and comparison with other tests. J Infect Dis 1984; 149:459-64; PMID:6371155; http://dx.doi.org/10.1093/infdis/149.3.459
  • Serdula MK, Halstead SB, Wiebenga NH, Herrmann KL. Serological response to rubella revaccination. JAMA 1984; 251:1974-7; PMID:6700099; http://dx.doi.org/10.1001/jama.1984.03340390028023
  • National Committee of Clinical Laboratory Scientists (NCCLS). Detection and Quantitation of Rubella IgG Antibody: Evaluation and Performance Criteria for Multiple Component Test Products,Specimen Handling, and Use of Test Products in the Clinical Laboratory; Approved Guideline. 1997 Wayne, PA
  • Terada K, Itoh Y, Wakabayashi T, Teranishi H, Akaike H, Ogita S, Ouchi K. Rubella specific cell-mediated and humoral immunity following vaccination in college students with low antibody titers. Vaccine 2015; 33(45):6093-8; PMID:26275479
  • Davidkin I, Peltola H, Leinikki P, Valle M. Duration of rubella immunity induced by two-dose measles, mumps and rubella (MMR) vaccination. A 15-year follow-up in Finland. Vaccine 2000; 18:3106-12; PMID:10856790; http://dx.doi.org/10.1016/S0264-410X(00)00139-0
  • Public Health Agency of Canada. Elimination of Measles, Rubella and Congenital Rubella Syndrome in Canada - Documentation and Verification Report. Pan American Health Organization, Regional Office of the World Health Organization; 2011:1-136
  • Gao Z, Wood JG, Burgess MA, Menzies RI, McIntyre PB, MacIntyre CR. Models of strategies for control of rubella and congenital rubella syndrome-a 40 year experience from Australia. Vaccine 2013; 31:691-7; PMID:23196206; http://dx.doi.org/10.1016/j.vaccine.2012.11.043
  • Bouthry E, Huzly D, Revello MG, Furione M, Grangeot-Keros L, Vauloup-Fellous C. An evaluation of nine Rubella IgG assays highlights many discrepancies in the interpretation of the results. ECCMID; 2014; Barcelona, Spain
  • Dimech W, Arachchi N, Cai J, Sahin T, Wilson K. Investigation into low-level anti-rubella virus IgG results reported by commercial immunoassays. Clin Vaccine Immunol 2013; 20 255-61; PMID:23254301; http://dx.doi.org/10.1128/CVI.00603-12
  • Weir E, Sider D. A refresher on rubella. CMAJ 2005; 172:1680-1; PMID:15967968; http://dx.doi.org/10.1503/cmaj.050590
  • Lee JY, Bowden DS. Rubella virus replication and links to teratogenicity. Clin Microbiol Rev 2000; 13:571-87; PMID:11023958; http://dx.doi.org/10.1128/CMR.13.4.571-587.2000
  • Koklu E, Kurtoglu S, Akcakus M, Koklu S, Gunes T, Kose M. Blueberry muffin syndrome owing to congenital rubella: case report. Ann Trop Paediatr 2006; 26:149-51; PMID:16709336; http://dx.doi.org/10.1179/146532806X107511
  • Centers for Disease Control and Prevention. Revised ACIP recommendation for avoiding pregnancy after receiving a rubella-containing vaccine. MMWR Morb Mortal Wkly Rep 2001; 50:1117; PMID:11794623

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.